Three-year outcomes of the TCD-17187 (Kanshas) drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery

Key Points

• The study aims to assess the long-term outcomes of TCD-17187 drug-coated balloons for treating atherosclerotic lesions.
• Randomized trial design with a registration ID of UMIN000034122.
• Participants treated with TCD-17187 drug-coated balloons for lesions in the superficial femoral and proximal popliteal arteries.
• Follow-up duration of three years to evaluate treatment outcomes.
• Three-year outcomes indicate improved vascular health in the treated arteries.
• Significant reduction in lesion reoccurrence rates compared to traditional interventions.

Abstract